Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | RAB9A | P51151 | 1/20 | 0.68 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | PRKACA | P17612 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23598723 | 0.96 | MEN1 (0.70) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL28670824 | 0.96 | RAB9A (0.62) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL16406991 | 0.90 | MEN1 (0.61) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL23196588 | 0.88 | MEN1 (0.59) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL20481867 | 0.87 | MEN1 (0.52) | MEN1KMT2ARAB9AASIC3ADORA2A | |
| SCHEMBL23312633 | 0.83 | L3MBTL1 (0.47) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL19412113 | 0.83 | MEN1 (0.46) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL23598431 | 0.82 | MEN1 (0.52) | MEN1KMT2ARAB9AASIC3ALDH1A1 | |
| SCHEMBL2263820 | 0.82 | MEN1 (0.53) | MEN1KMT2ARAB9AALDH1A1HPGD | |
| SCHEMBL16675045 | 0.82 | RAB9A (0.44) | MEN1KMT2ARAB9AASIC3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111978951-A | Organic light-emitting material, manufacturing method thereof and OLED device | 上海和辉光电有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-122036808-A | Organic electroluminescent material and device | 环球展览公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260136752-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-14 | — | — | US | disclosed |
| US-12534458-B2 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | MERCK SHARP & DOHME LLC (US) | 2026-01-27 | — | — | US | disclosed |
| US-12503643-B2 | Material for organic electroluminescence element, and organic electroluminescence element | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| US-20250107429-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-03-27 | — | — | US | disclosed |
| US-12201011-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240130220-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-04-18 | — | — | US | disclosed |
| EP-3615514-B1 | PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF | AVIARA PHARMACEUTICALS INC (US) | 2023-11-22 | — | — | EP | disclosed |
| EP-3615514-B1 | PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF | AVIARA PHARMACEUTICALS INC (US) | 2023-11-22 | — | — | EP | disclosed |
| US-20020058606-A1 | Treatment of sexual dysfunction | WARNER-LAMBERT COMPANY | 2002-05-16 | — | — | US | disclosed |
| US-6066597-A | Herbicidal 2-(hetero)aryloxy-6-arylpyridines and 2-aryl-4-(hetero)aryloxy-6-arylpyridines and 2-aryl-4-(hetero)aryloxypyrimidines | AMERICAN CYANAMID COMPANY (US) | 2000-05-23 | — | — | US | disclosed |
| US-6008161-A | Herbicidal 2-(hetero)aryloxy-6-arylpyridines and 2-aryl-4-(hetero) aryloxypyrimidines | AMERICAN CYANAMID COMPANY (US) | 1999-12-28 | — | — | US | disclosed |
| US-5849758-A | Herbicidal 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines | AMERICAN CYANAMID COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| US-5824624-A | HERBICIDES WITH CARRIERS OR SURFACTANTS | AMERICAN CYANAMID COMPANY (US) | 1998-10-20 | — | — | US | disclosed |
| CN-1175578-A | Herbicidal 2, 6 -disubstituted pyridines and 2, 4 -disubstituted pyrimidines | AMERICAN CYANAMID CO (US) | 1998-03-11 | — | — | CN | disclosed |
| EP-0823431-A1 | Herbicidal 2,6-disubstituted pyridines and 2,4-disubstituted pyrimidines | American Cyanamid Company (US) | 1998-02-11 | — | — | EP | disclosed |
| CN-1143078-A | 2,6-twice substituted pyridine and 2,4-twice substituted pyrimidine for berbicide | AMERICAN CYANAMID CO (US) | 1997-02-19 | — | — | CN | disclosed |
| US-5576338-A | ANTIALLERGENS, ANTIHISTAMINES, ANTIINFLAMMATORY AGENTS AND CYTOPROTECTIVE AGENTS FOR CARDIOVASCULAR DISORDERS | MERCK FROSST CANADA, INC. (CA) | 1996-11-19 | — | — | US | disclosed |
| EP-0723960-A1 | Herbicidal 2,6-disubstituted pyridines and 2,4-disubstituted pyrimidines | American Cyanamid Company (US) | 1996-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534458-B2 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | CHRNA6, CHRNA7, CHRNA5 | MEN1 4861/4885KMT2A 3415/4885RAB9A 771/4885 |
| US-12201011-B2 | Organic electroluminescent materials and devices | NSD3, CCND3, DRD3 | MEN1 2899/4885KMT2A 804/4885RAB9A 3374/4885 |
| US-20020058606-A1 | Treatment of sexual dysfunction | BRS3, GNRHR, VIPR2 | MEN1 2314/4885KMT2A 4654/4885RAB9A 1217/4885 |
| US-20250107429-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NSD3, CCND3, DRD3 | MEN1 2899/4885KMT2A 804/4885RAB9A 3374/4885 |
| US-20260136752-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, GLRA1 | MEN1 3787/4885KMT2A 3499/4885RAB9A 995/4885 |
| US-20240130220-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | MEN1 2439/4885KMT2A 3757/4885RAB9A 1151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.